FCMV

Foresite Capital Management V Portfolio holdings

AUM $80.7M
This Quarter Return
-3.56%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
–
10 Year Return
–
AUM
$130M
AUM Growth
+$130M
Cap. Flow
+$0
Cap. Flow %
0%
Top 10 Hldgs %
95.26%
Holding
14
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 85.76%
2 Consumer Staples 14.24%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ACRS icon
1
Aclaris Therapeutics
ACRS
$209M
$19.8M 15.23% 1,258,243 – –
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$19.3M 14.87% 3,335,346 – –
HIMS icon
3
Hims & Hers Health
HIMS
$9.57B
$18.5M 14.24% 3,319,786 – –
PRDS
4
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$17.4M 13.37% 9,400,515 – –
KNTE
5
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$10.5M 8.04% 875,001 – –
SLGC
6
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$10.2M 7.84% 3,516,472 – –
CMPX icon
7
Compass Therapeutics
CMPX
$483M
$10M 7.71% 4,400,000 – –
ACET icon
8
Adicet Bio
ACET
$59.9M
$9.67M 7.44% 680,000 – –
IVVD icon
9
Invivyd
IVVD
$204M
$4.48M 3.45% 1,431,826 – –
IRON icon
10
Disc Medicine
IRON
$2.07B
$3.99M 3.07% 2,435,125 – –
QSI icon
11
Quantum-Si Incorporated
QSI
$227M
$2.54M 1.95% 924,379 – –
ENTA icon
12
Enanta Pharmaceuticals
ENTA
$180M
$2.19M 1.69% 42,250 – –
ME
13
DELISTED
23andMe Holding Co. Class A Common Stock
ME
$1.16M 0.9% 406,913 – –
PHVS icon
14
Pharvaris
PHVS
$1.39B
$262K 0.2% 34,142 – –